Long-term use of gonadotropin-releasing hormone analogues before IVF in women with endometriosis

Current Opinion in Obstetrics and Gynecology

Volumn 19, Issue 3, 2007, Pages 284-288

  Tavmergen, Erol ^a   Ulukus, Murat ^a   Goker, Ege Nazan Tavmergen ^a  

^a EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Endometriosis; Gonadotropin releasing hormone analogue; IVF; Ovulation induction

Indexed keywords

DANAZOL; GONADORELIN DERIVATIVE;

DRUG EFFICACY; DRUG USE; EMBRYO TRANSFER; ENDOMETRIOSIS; FEMALE INFERTILITY; FERTILIZATION IN VITRO; HUMAN; LONG TERM CARE; PREGNANCY OUTCOME; PREGNANCY RATE; PRIORITY JOURNAL; REVIEW; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE;

ENDOMETRIOSIS; FEMALE; FERTILIZATION IN VITRO; GONADOTROPIN-RELEASING HORMONE; HUMANS; INTERLEUKINS; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34248390137     PISSN: 1040872X     EISSN: None     Source Type: Journal    
DOI: 10.1097/GCO.0b013e3281053a52     Document Type: Review

References (49)

1. Lessey BA. Medical management of endometriosis and infertility. Fertil Steril 2000; 73:1089-1096.
2. Dokras A, Olive D. Endometriosis and assisted reproductive technologies. Clin Obstet Gynecol 1999; 42:687-698.
3. Panidis DK, Matalliotakis IM. Subfertility associated with minimal to mild endometriosis: main mechanisms. Fertil Steril 1998; 43:1034-1042.
4. Harada T, Iwabe T, Terakawa N. Role of cytokines in endometriosis. Fertil Steril 2001; 76:1-10.
5. Mahutte NG, Arici A. Endometriosis and assisted reproductive technologies: are outcomes affected? Curr Opin Obstet Gynecol 2001; 13:275-279.
6. Trinder J, Cahill DJ. Endometriosis and infertility: the debate continues. Hum Fertil (Camb) 2002; 5 (1 Suppl):S21-S27.
7. Barnhart K, Dunsmoor-Su R, Coutifaris C. Effects of endometriosis on in vitro fertilization. Fertil Steril 2002; 77:1148-1155.
8. Cahill D, Wardle P, Maile L, et al. Pituitary-ovarian dysfunction as a cause for endometriosis-associated and unexplained infertility. Hum Reprod 1995; 10:3142-3146.
9. Akande AV, Asselin J, Keay SD, et al. Inhibin A, inhibin B and activin A in follicular fluid of infertile women with tubal damage, unexplained infertility and endometriosis. Am J Reprod Immunol 2000; 43:61-69.
10. Pellicer A, Valbuena D, Bauset C, et al. The follicular endocrine environment in stimulated cycles of women with endometriosis: steroid levels and embryo quality. Fertil Steril 1998; 69:1135-1141.
11. Verpoest WMJA, Cahil DJ, Harlow CR, Hull MGR. Relationship between midcycle luteinizing hormone surge quality and oocyte fertilization. Fertil Steril 2000; 73:75-77.
12. Harlow C, Cahill D, Maile L, et al. Reduced preovulatory granulosa cell steroidogenesis in women with endometriosis. J Clin Endocrinol Metab 1996; 81:426-429.
13. Pellicer A, Albert C, Mercader A, et al. The follicular and endocrine environment in women with endometriosis: local and systemic cytokine production. Fertil Steril 1998; 70:425-431.
14. Carlberg M, Nejaty J, Froysa B, et al. Elevated expression of tumor necrosis factor a in cultured granulosa cells from women with endometriosis. Hum Reprod 2000; 15:101-106.
15. Toya M, Saito H, Ohta N, et al. Moderate and severe endometriosis is associated with alterations in the cell cycle of granulosa cells in patients undergoing in vitro fertilization and embryo transfer. Fertil Steril 2000; 73:344-350.
16. Simon C, Gutierrez A, Vidal A, et al. Outcome of patients with endometriosis in assisted reproduction: results from in-vitro fertilization and oocyte donation. Fertil Steril 1994; 9:725-729.
17. Sung L, Mukherjee T, Takeshige T, et al. Endometriosis is not detrimental to embryo implantation in oocytes recipients. J Assist Reprod Genet 1997; 14:152-156.
18. Diaz I, Navarro J, Blasco L, et al. Impact of stage III-IV endometriosis on recipients of sibling oocytes: matched case-control study. Fertil Steril 2000; 74:31-34.
19. Pellicer A, Navarro J, Bosch E, et al. Endometrial quality in infertile women with endometriosis. Ann N Y Acad Sci 2001; 943:122-130.
20. Ulukus M, Cakmak H, Arici A. The role of endometrium in endometriosis. J Soc Gynecol Investig 2006; 13:467-476.
21. Kennedy S, Bergqvist A, Chapron C, et al. ESHRE guideline for the diagnosis and treatment of endometriosis. Hum Reprod 2005; 20:2698-2704.
22. Jacobson TZ, Barlow DH, Koninckx PR, et al. Laparoscopic surgery for subfertility associated with endometriosis. Cochrane Database Syst Rev 2002; (4):CD001398.
23. Adamson GD, Hurd SJ, Pasta DJ, Rodriguez BD. Laparoscopic endometriosis treatment: is it better? Fertil Steril 1993; 59:35-44.
24. Guzick DS, Silliman NP, Adamson GD, et al. Prediction of pregnancy in infertile women based on the American Society for Reproductive Medicine's revised classification of endometriosis. Fertil Steril 1997; 67:822-829.
25. Osuga Y, Koga K, Tsutsumi O, et al. Role of laparoscopy in the treatment of endometriosis-associated infertility. Gynecol Obstet Invest 2002; 53 (Suppl): 33-39.
26. Chapron C, Vercellini P, Barakat H, et al. Management of ovarian endometriomas. Hum Reprod Update 2002; 8:591-597.
27. Loh FH, Tan AT, Kumar J, Ng SC. Ovarian response after laparoscopic ovarian cystectomy for endometriotic cysts in 132 monitored cycles. Fertil Steril 1999; 72:316-321.
28. Gerber S, Ferreira DP, Spyer Prates LF, et al. Effects of previous ovarian surgery for endometriosis on the outcome of assisted reproduction treatment. Reprod Biomed Online 2002; 5:162-166.
29. Ho HY, Lee RK, Hwu YM, et al. Poor response of ovaries with endometrioma previously treated with cystectomy to controlled ovarian hyperstimulation. J Assist Reprod Genet 2002; 19:507-511.
30. Aboulghar MA, Mansour RT, Serour GI, et al. The outcome of in vitro fertilization in advanced endometriosis with previous surgery: a case-controlled study. Am J Obstet Gynecol 2003; 188:371-375.
31. Canis M, Pouly JL, Tamburro S, et al. Ovarian response during IVF-embryo transfer cycles after laparoscopic ovarian cystectomy for endometriotic cysts of >3cm in diameter. Hum Reprod 2001; 16:2583-2586.
32. Manconi G, Vilela M, Quintana R, Sueldo C. Laparoscopic ovarian cystectomy of endometriomas does not affect the ovarian response to gonadotropin stimulation. Fertil Steril 2002; 78:876-878.
33. Marcus SF, Edwards RG. High rates of pregnancy after long-term downregulation of women with severe endometriosis. Am J Obstet Gynecol 1994; 171:812-817.
34. Nakamura K, Oosawa M, Kondou I, et al. Menotropin stimulation after prolonged gonadotropin releasing hormone agonist pretreatment for in vitro fertilization in patients with endometriosis. J Assist Reprod Genet 1992; 9:113-117.
35. Curtis P, Jackson A, Bernard A, Shaw RW. Pretreatment with gonadotrophin releasing hormone (GnRH) analogue prior to in vitro fertilization for patients with endometriosis. Eur J Obstet Gynecol Reprod Biol 1993; 52:211-216.
36. Dicker D, Goldman GA, Ashkenazi J, et al. The value of pretreatment with gonadotrophin releasing hormone (GnRH) analogue in IVF-ET therapy of severe endometriosis. Hum Reprod 1990; 5:418-420.
37. Oehninger S, Brzyski RG, Muasher SJ, et al. In-vitro fertilization and embryo transfer in patients with endometriosis: impact of a gonadotrophin releasing hormone agonist. Hum Reprod 1989; 4:541-544.
38. Dale PO, Tanbo T, Abyholm T. Endometriosis-associated infertility treated by long-term gonadotropin-releasing hormone agonist administration and assisted fertilization. J In Vitro Fert Embryo Transf 1990; 7:180-181.
39. Chedid S, Camus M, Smitz J, et al. Comparison among different ovarian stimulation regimens for assisted procreation procedures in patients with endometriosis. Hum Reprod 1995; 10:2406-2411.
40. Ruiz-Velasco V, Allende S. Goserelin followed by assisted reproduction: results in infertile women with endometriosis. Int Fertil Womens Med 1998; 43:18-23.
41. Dicker D, Goldman JA, Levy T, et al. The impact of long-term gonadotropinreleasing hormone analogue treatment on preclinical abortions in patients with severe endometriosis undergoing in vitro fertilization-embryo transfer. Fertil Steril 1992; 57:597-600.
42. Surrey ES, Silverberg KM, Surrey MW, Schoolcraft WB. Effect of prolonged gonadotropin-releasing hormone agonist therapy on the outcome of in vitro fertilization-embryo transfer in patients with endometriosis. Fertil Steril 2002; 78:699-704.
43. Rickes D, Nickel I, Kropf S, Kleinstein J. Increased pregnancy rates after ultralong postoperative therapy with gonadotropin-releasing hormone analogs in patients with endometriosis. Fertil Steril 2002; 78:757-762.
44. Salam HN, Garcia-Velasco JA, Dias S, Arici A. Long-term pituitary down-regulation before in vitro fertilization (IVF) for women with endometriosis. Cochrane Database Syst Rev 2006; (25);CD004635. This metaanalysis includes three randomized controlled trials and shows that longterm use of GnRH agonist prior to ARTs increases the clinical pregnancy rates in women with endometriosis.
45. Fabregues F, Balasch J, Creus M, et al. Long-term down-regulation does not improve pregnancy rates in an in vitro fertilization program. Fertil Steril 1998; 70:46-51.
46. Seli E, Arici A. Endometriosis: interactions of immune and endocrine systems. Semin Reprod Med 2003; 21:135-144.
47. Kennedy SH, Starkey PM, Sargent IL, et al. Antiendometrial antibodies in endometriosis measured by an enzyme-linked immunosorbent assay before and after treatment with danazol and nafarelin. Obstet Gynecol 1990; 75:914-918.
48. Taketani Y, Kuo TM, Mizuno M. Comparison of cytokine levels and embryo toxicity in peritoneal fluid in infertile women with untreated or treated endometriosis. Am J Obstet Gynecol 1992; 167:265-270.
49. Imai A, Takagi A, Tamaya T. Gonadotropin-releasing hormone analog repairs reduced endometrial cell apoptosis in endometriosis in vitro. Am J Obstet Gynecol 2000; 182:1142-1146.